MWB raises target for Drägerwerk stock from EUR 114 to EUR 130

Published on 10/07/2026 at 13:33 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Second-quarter 2026 revenue rose 8.60 percent to EUR 847.30 million. Drägerwerk stock costs EUR 114.90 on October 7, 2026 after EUR 115.60.

Architekturvisualisierung eines modernen Medizintechnik-Forschungsgebäudes mit Glasfassade — Drägerwerk AG & Co. KGaA modernes Forschungsgebäude Medizintechnik Glasfassade Architekturrender Unternehmensanlage DE0005550636, Illustration mit AI erstellt.

Drägerwerk (DE0005550636) is trading at EUR 114.90 at Lang & Schwarz on October 7, 2026 at 1:28 p.m. CEST, minus 0.61 percent versus the prior close of EUR 115.60. MWB Research raised its price target for the medical technology company from EUR 114.00 to EUR 130.00 on September 8, 2026, according to Finanztrends.

MWB raises target to EUR 130

The change puts the new target EUR 15.00 above the previous EUR 115.00 target, a 13.16 percent increase. At the October 7 Lang & Schwarz price, EUR 130.00 would stand 13.15 percent above the stock price, keeping the analyst view above the market quotation.

The target revision followed Drägerwerk's strong first-half performance and a more constructive view of margins. The company operates across medical and safety technology, making operating leverage and demand in both divisions important to the valuation case.

Second-quarter profit jumps 162.10 percent

Drägerwerk reported EUR 847.30 million in revenue for the second quarter of 2026, up 8.60 percent from the prior-year quarter, while profit reached EUR 29.50 million, up 162.10 percent year over year, according to Aktienmagazin. The combination gives investors two distinct signals: sales growth remained positive, while earnings expanded much faster than revenue.

Dräger's investor-relations page lists its current 2026 outlook at 2.00 to 6.00 percent currency-adjusted revenue growth and a 5.00 to 7.50 percent EBIT margin, with DVA of EUR 20.00 million to EUR 120.00 million, according to Dräger. The broad ranges leave execution and margin delivery as the main variables for the next results update.

Third-quarter results set for October 29

Drägerwerk's next earnings release is scheduled for October 29, 2026, with an earnings presentation also listed for that date by Marketscreener. That date gives the market a defined checkpoint for testing whether the second-quarter profit acceleration is continuing.

Stock trades below its prior close

Drägerwerk stock was trading at EUR 114.90 at Lang & Schwarz on October 7, 2026 at 1:28 p.m. CEST, minus 0.61 percent versus the prior close of EUR 115.60 on October 6, 2026. The further course of trading is shown by the continuously updated real-time quote of Drägerwerk stock.